Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record for a completed Phase 2 Sjögren’s syndrome trial is displayed, with details on study design, participant eligibility, interventions, outcomes, locations, and publications. Study history and supporting documents, including the protocol and statistical analysis plan, are also shown.
    Difference
    81%
    Check dated 2026-11-08T01:12:12.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T19:26:53.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH website changes and says “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T19:32:20.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T22:07:33.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:01:15.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page previously displaying a study record now shows a 403 Forbidden error, with site chrome (navigation/footer) still visible, indicating the content is temporarily inaccessible.
    Difference
    19%
    Check dated 2026-09-19T19:18:15.000Z thumbnail image

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.